Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAS-block study in CKD
NCT00235287Phase 4Unknown
- Sponsor
- Herlev Hospital
- Start
- Sep 2005
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of candesartan, enalapril in chronic kidney disease (CKD), sponsored by Herlev Hospital. Status: unknown.
02
Drugs
candesartanenalapril
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00235287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235287.